Nah!; ). We were all hoping that the 700,000 extra pages in the application meant something good. I was hoping that it might be tissue agnostic designation proof but other things started to look more likely for a while. Now that designation is back in focus a little better and with it comes a renewed understanding of the importance of Flaskworks. Best wishes.
And to think of all the brickbats and rocks thrown at management and not just from the 'fuddy buddy' crowd, especially during the last two years.
Looking back, LP & Co: Anticipated the confoundment of PFS by the crossover arm and so extended the trial to get 5 years of OS data. They knew about the WHO effort to update the definition of GBM and waited for that to be publicized to start data lock. They anticipated the analysis issues and revised the SAP to use the ECA. And course, the focus on manufacturing throughout these years.